Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”

Vaccines (Nov 2023)

Affiliations

Maarten J. Postma: Department of Health Sciences, Unit of Global Health, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands
Chih-Yuan Cheng: Janssen Pharmaceutica NV, 2340 Beerse, Belgium
Nasuh C. Buyukkaramikli: Janssen Pharmaceutica NV, 2340 Beerse, Belgium
Luis Hernandez Pastor: Janssen Pharmaceutica NV, 2340 Beerse, Belgium
Ine Vandersmissen: Janssen-Cilag NV, 2340 Beerse, Belgium
Thierry Van Effelterre: Janssen Pharmaceutica NV, 2340 Beerse, Belgium
Peter Openshaw: National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK
Steven Simoens: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium

Abstract

We have read the commentary from Baudouin Standaert [...]